StonvexLoading…
StonvexStonvexStonvexCore line items from DPZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-28 | Annual 2024 2024-12-29 | Annual 2023 2023-12-31 | Annual 2023 2023-01-01 |
|---|---|---|---|---|
Revenue | $4.94B | $4.71B | $4.48B | $4.54B |
Operating Income | $953.97M | $879.00M | $819.52M | $767.92M |
Net Income | $601.70M | $584.17M | $519.12M | $452.26M |
EPS (Diluted) | $17.57 | $16.69 | $14.66 | $12.53 |
Total Assets | $1.72B | $1.74B | $1.67B | $1.60B |
Total Liabilities | $5.62B | $5.70B | $5.75B | $5.79B |
Cash & Equivalents | $125.67M | $186.13M | $114.10M | $60.36M |
Free Cash Flow OCF − CapEx | $671.50M | $512.01M | $485.47M | $388.08M |
Shares Outstanding | 33.63M | 34.28M | 34.73M | 35.42M |